🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LPC
$LPCN
🔒 US EquitiesLipocine Inc
AVG HISTORICAL GAP
-0.50%
MAX GAP RECORD
+6.59%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LPCN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LPCN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN) |
+0.95%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
-2.06%
|
| Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN) |
+0.89%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
+1.56%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN) |
-1.82%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+1.87%
|
| Mar 13, 2025 Earnings Release 2025-03-13 (BEFORE OPEN) |
-3.12%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN) |
-0.99%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.1%
Bullish Gaps (3)
Bearish Gaps (7)
Neutral / Flat (5)
📖 Intelligence Summary
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗